Last updated on May 2018

Copanlisib and Rituximab in Relapsed Indolent B-cell Non-Hodgkin's Lymphoma (iNHL)


Find a site near you

Start Over

Bayer Clinical Trials Contact

Louisville, KY United States
  Connect »

Bayer Clinical Trials Contact

Goldsboro, NC United States
  Connect »

Bayer Clinical Trials Contact

Cleveland, OH United States
  Connect »

Bayer Clinical Trials Contact

Allentown, PA United States
  Connect »

Bayer Clinical Trials Contact

Watertown, SD United States
  Connect »

Bayer Clinical Trials Contact

Salt Lake City, UT United States
  Connect »

Bayer Clinical Trials Contact

Ciudad Auton. de Buenos Aires, Argentina
  Connect »

Bayer Clinical Trials Contact

Bruxelles - Brussel, Belgium
  Connect »

Bayer Clinical Trials Contact

Vandoeuvre-les-nancy, France
  Connect »

Bayer Clinical Trials Contact

Jeollanam-do, Korea, Republic of
  Connect »

Asan Medical Center

Seoul, Korea, Republic of
  Connect »

Bayer Clinical Trials Contact

Esch-sur-alzette, Luxembourg
  Connect »

Bayer Clinical Trials Contact

Vila Nova de Gaia, Portugal
  Connect »

Bayer Clinical Trials Contact

Chelyabinsk, Russian Federation
  Connect »

Bayer Clinical Trials Contact

Irkutsk, Russian Federation
  Connect »

Bayer Clinical Trials Contact

Kemerovo, Russian Federation
  Connect »

Bayer Clinical Trials Contact

Krasnoyarsk, Russian Federation
  Connect »

Bayer Clinical Trials Contact

Novosibirsk, Russian Federation
  Connect »

Bayer Clinical Trials Contact

St. Petersburg, Russian Federation
  Connect »

Bayer Clinical Trials Contact

Volgograd, Russian Federation
  Connect »

Bayer Clinical Trials Contact

West Covina, CA United States
  Connect »

Bayer Clinical Trials Contact

Farmington Hills, MI United States
  Connect »

Bayer Clinical Trials Contact

Las Vegas, NV United States
  Connect »

Bayer Clinical Trials Contact

Englewood, NJ United States
  Connect »